Pfizer presented data ​on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its ...

The pharma company doesn’t have any obesity drugs on the market. Here’s how it plans to change that, and become an industry leader.

Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor Starboard Value, saying he agreed with some of ...

Pfizer Inc (NYSE:PFE) has unveiled detailed strategy plans and clinical data for its experimental weight-loss injection, aiming to secure a foothold in a competitive market currently dominated by ...

Pfizer's monthly obesity shot has side-effects similar to Wegovy in midstage trial. Most visited website in Sri Lanka.